AI assistant
Sending…
CAPRICOR THERAPEUTICS, INC. — Director's Dealing 2012
Aug 9, 2012
33192_dirs_2012-08-09_ecce8c82-b6fc-405d-b851-a28d9a3c1191.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Nile Therapeutics, Inc. (NLTX)
CIK: 0001133869
Period of Report: 2012-08-06
Reporting Person: HORTON DARLENE P (Director, President & CEO)
More from CAPRICOR THERAPEUTICS, INC.
Interim / Quarterly Report
2026
May 13
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Director's Dealing
2026
Mar 28
Share Issue/Capital Change
2026
Jan 30
Major Shareholding Notification
2026
Jan 26
Director's Dealing
2026
Jan 7
Director's Dealing
2026
Jan 7
Director's Dealing
2026
Jan 7
Director's Dealing
2026
Jan 7